Semaglutide is the active ingredient in a few prescription medications for type 2 diabetes and weight loss. Ozempic is one of them. You cannot get semaglutide as a generic drug.
Medically reviewed by Alisha D. Sellers, BS Pharmacy, PharmD
In the evolving landscape of medical advancements, both semaglutide and Ozempic have gained recent attention for their uses in diabetes management and weight loss.
What is the difference between semaglutide and Ozempic?
Semaglutide is an active pharmaceutical ingredient. An active ingredient is what makes a drug work.
Ozempic, on the other hand, is a brand-name medication made with that active ingredient.
What is semaglutide?
Semaglutide is the active ingredient in several medications, including Ozempic.
Semaglutide belongs to the drug class known as glucagon-like peptide-1 (GLP-1) receptor agonists. It works by stimulating GLP-1 receptors in the body. GLP-1 is a hormone your body releases when you eat.
A 2021 study explains that the effects of GLP-1 — and semaglutide, which mimics it — include:
increased insulin
suppressed glucagon
slowed stomach emptying
Combined, these effects may help stabilize your blood sugar levels and reduce appetite. This makes semaglutide a valuable medication for managing diabetes and effective in weight loss efforts.
You cannot buy a generic semaglutide medication, but the Food and Drug Administration (FDA) has approved three brand-name versions.
What is Ozempic?
Ozempic is a brand name for semaglutide. According to the Ozempic drug label, you administer the drug once per week as an injection under your skin. That said, your doctor will always prescribe the right amount for you.
lowering blood sugar levels in adults with type 2 diabetes, in addition to physical activity and eating habit changes
reducing the risk of heart disease complications like strokes or heart attacks in adults with type 2 diabetes and heart disease
However, Ozempic is also prescribed off-label as a weight loss drug. “Off-label” refers to using a medication for a different purpose than the one the FDA approved it for.
Due to its effectiveness in weight management for people with obesity, more people are now interested in using Ozempic for weight loss only.
100% online care
Treatment plans in 15 minutes or less for 40+ conditions.
Rybelsus is an oral semaglutide medication that you swallow. Like Ozempic, it is FDA-approved to lower blood sugar levels in adults with type 2 diabetes, in combination with diet and exercise changes. It is not approved to reduce the risk of heart disease complications.
The Rybelsus label explains that you take it daily by mouth. It may be a suitable alternative to Ozempic for people who don’t want a weekly injection. A doctor can help determine the proper dosage for you.
Wegovy
Wegovy is another brand name for semaglutide. The label instructs that, like Ozempic, you administer Wegovy as a weekly injection — though the dose may be higher.
Wegovy is FDA-approved for weight loss in people ages 12 years and over with obesity or who have overweight and weight-related health concerns, such as diabetes or high blood pressure.
The label instructs that you use it alongside diet and exercise to further support weight management. A doctor can help you figure out the best treatment plan for your condition.
If you need help covering the cost of medications, the free Optum Perks Discount Card could help you save up to 80% on prescription drugs. Follow the links on drug names for savings on that medication, or search for a specific drug here.
Off-label semaglutide uses
Besides blood sugar management and weight loss, semaglutide medications may have potential off-label uses:
Non-alcoholic fatty liver disease (NAFLD): A 2022 systematic review concludes that GLP-1 receptor agonists like semaglutide may support NAFLD treatment.
Neurodegenerative diseases: A narrative review from 2022 suggests that semaglutide might help protect against neurodegenerative diseases like Alzheimer’s and Parkinson’s disease.
Polycystic ovary syndrome (PCOS): A 2021 narrative review notes that semaglutide also has potential uses for PCOS management.
It’s important to note that these uses are not FDA-approved and that research is still in its early days. More, larger, and better studies are needed to learn more about semaglutide’s potential uses outside of type 2 diabetes and weight management.
Free prescription coupons
Seriously … free. Explore prices that beat the competition 70% of the time.
Non-drug options include lifestyle changes like diet and exercise. In some cases, a doctor might recommend weight loss surgery, like a gastric sleeve. A healthcare professional can help determine the best option for your unique needs.
Lifestyle changes like getting more physical activity and eating a lower-calorie diet may also support diabetes management. A doctor can advise you on which approach, or combination of approaches, is best for you and your health.
Semaglutide is an active pharmaceutical ingredient, while Ozempic is one of the brand names for semaglutide. You cannot get semaglutide as a generic medication. Other brand names for semaglutide are Wegovy and Rybelsus.
Semaglutide promotes weight loss in adults with overweight and obesity and helps manage blood sugar levels in people with type 2 diabetes. Ozempic is only FDA-approved for the latter.
If you are interested in learning more about diabetes or weight loss treatment, you can speak with a healthcare professional to determine the most suitable approach for your specific health needs.
Han SH, et al. (2023). Public interest in the off-label use of glucagon-like peptide 1 agonists (Ozempic) for cosmetic weight loss: A Google Trends analysis. https://pubmed.ncbi.nlm.nih.gov/37402640/
Luo Q, et al. (2022). Efficacy of off-label therapy for non-alcoholic fatty liver disease in improving non-invasive and invasive biomarkers: A systematic review and network meta-analysis of randomized controlled trials. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914474/
Mahapatra MK, et al. (2022). Therapeutic potential of semaglutide, a newer GLP-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: A narrative review. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159769/